In vitro activity of Ro 15-8074 and Ro 19-5247, two orally administered cephalosporin metabolites
about
Pharmacokinetics of cefetamet pivoxil (Ro 15-8075) with ascending oral doses in normal healthy volunteers.Effects of timing of food and fluid volume on cefetamet pivoxil absorption in healthy normal volunteersInfluence of antacid and ranitidine on the pharmacokinetics of oral cefetamet pivoxil.Antimicrobial activity and disk diffusion susceptibility testing of U-76,253A (R-3746), the active metabolite of the new cephalosporin ester, U-76,252 (CS-807)Pharmacokinetics of cefetamet (Ro 15-8074) and cefetamet pivoxil (Ro 15-8075) after intravenous and oral doses in humans.Pharmacokinetics of intravenous cefetamet and oral cefetamet pivoxil in patients with renal insufficiency.Future directions in antimicrobial chemotherapy.Antimicrobial activity, spectrum, and recommendations for disk diffusion susceptibility testing of ceftibuten (7432-S; SCH 39720), a new orally administered cephalosporin.Antimicrobial activity of Ro 15-8074, active metabolite of a new oral cephalosporin (Ro 15-8075), against 7,775 recent clinical isolates.In vitro activity of Ro 19-5247 (T-2525) and interpretive criteria for disk diffusion susceptibility testingPreliminary antimicrobial susceptibility interpretive criteria for cefetamet (Ro 15-8074) and cefteram (Ro 19-5247) disk tests.Disk diffusion susceptibility testing and broth microdilution quality control guidelines for BMY-28100, a new orally administered cephalosporinPharmacokinetics of intravenous cefetamet (Ro 15-8074) and oral cefetamet pivoxil (Ro 15-8075) in young and elderly subjects.Comparative in vitro antibacterial activities of two new oral cephalosporins, ceftetrame (Ro 19-5247) and cefetamet (Ro 15-8074)Bioavailability of syrup and tablet formulations of cefetamet pivoxil.Using Monte Carlo simulation to determine optimal dosing regimen for cefetamet sodium for injection.In vitro susceptibility of Haemophilus influenzae to cefaclor, cefixime, cefetamet and loracarbef.In vitro antibacterial properties of cefetamet and in vivo activity of its orally absorbable ester derivative, cefetamet pivoxil.Comparative in vitro activity of the two new oral cephalosporin metabolites RO 19-5247 and RO 15-8074.
P2860
Q33742875-DABF5C15-B174-448E-AF95-3A2FD9004397Q35269538-E96F0D43-E13A-47B5-94FC-13D025816340Q35272898-77A95539-7C61-4AA8-9B81-F58B88648E4BQ35297977-DDE6CADB-9680-428B-B530-D86D9F883F59Q35300598-F487E516-65BC-4C2B-B2C2-BF5D3983B86FQ35360233-C444C14D-479B-42E1-9CE1-44D8AB9EF584Q35530705-DD6E47CB-54A2-4FE6-B35E-952331D09211Q35564509-82B4E40A-4529-4B14-93F4-C51C86639FA3Q35654046-4FA85E96-9A1E-4C1E-BF5C-269373F0348BQ37215130-7E634D4A-0F4E-4C40-AF70-D5D62E0D0D07Q37219636-73BBC71F-F24B-4E22-AF42-CB7863AF9649Q37222684-CC9AA6BE-8CA1-4886-9D72-0BFB991D1064Q39815033-2BB36F6D-6199-4DDA-A167-C9347F639159Q39827907-5A5FC51B-CDE2-4869-B76C-789FFAE3FC8AQ39883778-8EF5B336-C47A-489A-B6F3-FB1650E56CC2Q41727504-52F12928-FF77-4ADE-97B3-CA041EE0BA51Q54265240-4593D955-D977-4BEA-95F3-83BA6828A6EBQ54353071-F650388F-DF97-45BB-9906-2B4962F12015Q54399397-C4F1F4DE-8F67-4748-BEF4-0CAB0A9AEDC7
P2860
In vitro activity of Ro 15-8074 and Ro 19-5247, two orally administered cephalosporin metabolites
description
1986 nî lūn-bûn
@nan
1986年の論文
@ja
1986年学术文章
@wuu
1986年学术文章
@zh-cn
1986年学术文章
@zh-hans
1986年学术文章
@zh-my
1986年学术文章
@zh-sg
1986年學術文章
@yue
1986年學術文章
@zh
1986年學術文章
@zh-hant
name
In vitro activity of Ro 15-807 ...... ered cephalosporin metabolites
@en
In vitro activity of Ro 15-807 ...... red cephalosporin metabolites.
@nl
type
label
In vitro activity of Ro 15-807 ...... ered cephalosporin metabolites
@en
In vitro activity of Ro 15-807 ...... red cephalosporin metabolites.
@nl
prefLabel
In vitro activity of Ro 15-807 ...... ered cephalosporin metabolites
@en
In vitro activity of Ro 15-807 ...... red cephalosporin metabolites.
@nl
P2860
P356
P1476
In vitro activity of Ro 15-807 ...... ered cephalosporin metabolites
@en
P2093
P2860
P304
P356
10.1128/AAC.29.6.1067
P407
P577
1986-06-01T00:00:00Z